Search Within

Population Sciences Research Program

  1. "American Association for Cancer Research"
  2. "Clifford Hudis"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (14)
Groups
  1. Breast Medicine Service (43)
  2. Department of Medicine (43)
  3. Solid Tumor Oncology Division (43)
  4. Survivorship Research (43)
  5. Epidemiology and Biostatistics (25)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)

More Groups

People
  1. Clifford Hudis (43)
  2. Larry Norton (22)
  3. Maura Dickler (19)
  4. Chau Dang (15)
  5. Gabriella D'Andrea-Carlino (13)
  6. Neil Iyengar (13)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (5)
  5. 2015 (6)
  6. 2014 (1)

More Years

Publications
  1. Cancer Research (26)
  2. Clinical Cancer Research (10)
  3. Cancer Prevention Research (3)
  4. Cancer Epidemiology Biomarkers and Prevention (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
Publishers
  1. American Association for Cancer Research (43)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Obesity-associated breast inflammation among Hispanic/Latina breast cancer patients
    Journal Article

    Greenlee, H.; Shi, Z.; Hibshoosh, H.; Giri, D. D.; Ahmed, A.; Williams, S.; Falcone, D. J.; Winston, L. A.; Zhou, X. K.; Hudis, C. A.; more...
    Cancer Prevention Research (2019)

    Fulltext@MSK | Save
  • Adiposity, inflammation, and breast cancer pathogenesis in Asian Women
    Journal Article

    Iyengar, N. M.; Chen, I. C.; Zhou, X. K.; Giri, D. D.; Falcone, D. J.; Winston, L. A.; Wang, H.; Williams, S.; Lu, Y. S.; Hsueh, T. H.; more...
    Cancer Prevention Research (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index
    Meeting Abstract

    Iyengar, N. M.; Arown, K.; Khou, X.; Subbaramaiah, K.; Giri, D. D.; Gucalp, A.; Howe, L. R.; Zahid, H.; Bhardwaj, P.; Wendel, N. K.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
    Meeting Abstract

    Argolo, D.; Friedman, M.; Smyth, L.; Iyengar, N.; Singh, J.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Cardiac safety of trastuzumab without an anthracycline in patients with HER2-positive early stage breast cancer: A single center experience
    Meeting Abstract

    Mukku, R. B.; Verma, S.; Liu, J.; Steingart, R.; Hudis, C.; Yu, A. F.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Systemic correlates of white adipose tissue inflammation in early-stage breast cancer
    Journal Article

    Iyengar, N. M.; Zhou, X. K.; Gucalp, A.; Morris, P. G.; Howe, L. R.; Giri, D. D.; Morrow, M.; Wang, H.; Pollak, M.; Jones, L. W.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save